HCA Healthcare Beats Q1 EPS Estimates, Reaffirms Guidance, and Repurchases $1.57B in Shares

summarizeSummary

HCA Healthcare announced Q1 2026 results, beating EPS estimates, reaffirming its full-year guidance, and executing a substantial $1.57 billion share repurchase.

check_boxKey Events

• Q1 Earnings Beat Expectations

  HCA Healthcare reported diluted earnings per share of $7.15 for Q1 2026, surpassing analyst estimates of $7.00. Revenues increased 4.3% to $19.109 billion compared to the prior year.

• Full-Year Guidance Reaffirmed

  The company reaffirmed its previously issued 2026 estimated guidance ranges, maintaining its outlook for the full year despite a dynamic operating environment.

• Significant Share Repurchases

  During the first quarter of 2026, HCA Healthcare repurchased 3.157 million shares of its common stock at a cost of $1.571 billion, with $9.179 billion remaining under its authorization as of March 31, 2026.

• Quarterly Dividend Declared

  The Board of Directors declared a quarterly cash dividend of $0.78 per share, payable on June 30, 2026, to stockholders of record on June 16, 2026.

auto_awesomeAnalysis

HCA Healthcare reported first-quarter earnings that surpassed analyst expectations, demonstrating solid financial performance despite some operational headwinds. The company's diluted EPS of $7.15 exceeded estimates, and revenues also saw a healthy increase. The reaffirmation of its full-year 2026 guidance, originally issued on January 27, 2026, provides stability and confidence in its outlook. Furthermore, the significant repurchase of $1.571 billion in common stock during the quarter underscores the company's commitment to returning capital to shareholders and reflects strong cash flow generation. This substantial capital return, representing a notable portion of its market capitalization, is a strong positive signal.